PetMed Express Inc (PETS) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.281x

Based on the latest financial reports, PetMed Express Inc (PETS) has a cash flow conversion efficiency ratio of -0.281x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-9.21 Million) by net assets ($32.77 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

PetMed Express Inc - Cash Flow Conversion Efficiency Trend (2000–2026)

This chart illustrates how PetMed Express Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read PETS current and long-term liabilities for a breakdown of total debt and financial obligations.

PetMed Express Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of PetMed Express Inc ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Samebest Co Ltd
TWO:8489
-0.017x
Fonet Bilgi Teknolojileri AS
IS:FONET
0.102x
Thonburi Medical Centre Public Company Limited
BK:KDH
0.051x
Broendbyernes IF Fodbold AS
CO:BIF
-0.007x
Aether Holdings, Inc.
NASDAQ:ATHR
-0.299x
Sinil Pharmaceutical Co. Ltd
KQ:012790
0.017x
Ege Seramik Sanayi ve Ticaret AS
IS:EGSER
-0.103x
Mildex Optical
TWO:4729
0.002x

Annual Cash Flow Conversion Efficiency for PetMed Express Inc (2000–2026)

The table below shows the annual cash flow conversion efficiency of PetMed Express Inc from 2000 to 2026. For the full company profile with market capitalisation and key ratios, see PETS market cap overview.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2026-03-31 $85.13 Million $4.72 Million 0.055x +24.18%
2024-03-31 $96.73 Million $4.32 Million 0.045x -82.35%
2023-03-31 $109.97 Million $27.80 Million 0.253x +94.34%
2022-03-31 $142.19 Million $18.50 Million 0.130x -54.14%
2021-03-31 $141.28 Million $40.08 Million 0.284x -5.06%
2020-03-31 $130.01 Million $38.84 Million 0.299x -10.85%
2019-03-31 $134.68 Million $45.14 Million 0.335x +3.77%
2018-03-31 $115.73 Million $37.38 Million 0.323x -36.12%
2017-03-31 $93.37 Million $47.20 Million 0.506x +99.79%
2016-03-31 $83.19 Million $21.05 Million 0.253x -40.43%
2015-03-31 $75.44 Million $32.04 Million 0.425x +120.84%
2014-03-31 $70.22 Million $13.51 Million 0.192x -7.35%
2013-03-31 $64.01 Million $13.29 Million 0.208x -17.35%
2012-03-31 $81.18 Million $20.39 Million 0.251x -19.07%
2011-03-31 $97.00 Million $30.11 Million 0.310x +8.58%
2010-03-31 $96.86 Million $27.69 Million 0.286x +43.19%
2009-03-31 $74.97 Million $14.97 Million 0.200x -30.95%
2008-03-31 $67.03 Million $19.38 Million 0.289x -5.99%
2007-03-31 $53.86 Million $16.56 Million 0.308x +12.63%
2006-03-31 $37.64 Million $10.28 Million 0.273x -20.80%
2005-03-31 $24.22 Million $8.35 Million 0.345x +336.38%
2004-03-31 $13.99 Million $1.11 Million 0.079x -54.46%
2003-03-31 $5.59 Million $970.30K 0.173x -42.32%
2002-03-31 $1.58 Million $476.02K 0.301x +121.76%
2001-03-31 $757.29K $-1.05 Million -1.382x -610.46%
2000-03-31 $1.63 Million $-317.24K -0.195x --

About PetMed Express Inc

NASDAQ:PETS USA Pharmaceutical Retailers
Market Cap
$49.22 Million
Market Cap Rank
#21942 Global
#4650 in USA
Share Price
$2.30
Change (1 day)
+2.68%
52-Week Range
$1.60 - $4.19
All Time High
$44.49
About

PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional suppleme… Read more